These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. Taylor G; Houston JB; Shaffer J; Mawer G Br J Clin Pharmacol; 1983 Mar; 15(3):287-93. PubMed ID: 6849764 [TBL] [Abstract][Full Text] [Related]
3. Serum neuroleptic concentrations and tardive dyskinesia. Jeste DV; Linnoila M; Wagner RL; Wyatt RJ Psychopharmacology (Berl); 1982; 76(4):377-80. PubMed ID: 6126895 [TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Morgenstern H; Glazer WM Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845 [TBL] [Abstract][Full Text] [Related]
5. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study. Chan CH; Chan HY; Chen YC Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Soares-Weiser K; Rathbone J Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ; Soares KV Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546 [TBL] [Abstract][Full Text] [Related]
9. Early course of new-onset tardive dyskinesia in older patients. Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454 [TBL] [Abstract][Full Text] [Related]
10. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
11. Butaperazine pharmacokinetics in tardive dyskinesia. Wolf ME; Javaid JI; Mosnaim AD; Davis JM Biopharm Drug Dispos; 1985; 6(2):223-7. PubMed ID: 2860932 [No Abstract] [Full Text] [Related]
12. Tardive dyskinesia and plasma homovanillic acid. Moore DC; Glazer WM; Bowers MB; Heninger GR Biol Psychiatry; 1983 Dec; 18(12):1393-402. PubMed ID: 6140961 [TBL] [Abstract][Full Text] [Related]
14. Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women. Richardson MA; Reilly MA; Read LL; Flynn CJ; Suckow RF; Maher TJ; Sziraki I Psychopharmacology (Berl); 1999 Apr; 143(4):347-57. PubMed ID: 10367551 [TBL] [Abstract][Full Text] [Related]
16. Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients. Gardos G; Samu I; Kallos M; Cole JO Psychopharmacology (Berl); 1980; 71(1):29-34. PubMed ID: 6109346 [TBL] [Abstract][Full Text] [Related]
17. The natural history of tardive dyskinesia. Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068 [TBL] [Abstract][Full Text] [Related]
18. Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine. DiGregorio GJ; Ruch E J Pharm Sci; 1980 Dec; 69(12):1457-9. PubMed ID: 7463341 [TBL] [Abstract][Full Text] [Related]